Literature DB >> 12898159

Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas.

Martin Hasselblatt1, Werner Paulus.   

Abstract

Pattern and extent of epithelial membrane antigen (EMA) immunoreactivity in ependymomas as compared to other glial tumors have only been investigated in small series. To determine sensitivity and specificity of EMA staining, 54 ependymomas were evaluated in comparison to 54 glioblastomas, 43 fibrillary astrocytomas and 21 oligodendrogliomas. Distinct punctate intracytoplasmic EMA immunoreactivity was observed in 48/54 ependymomas (89%), whereas ring-like EMA staining was observed in 17/54 ependymomas (31%). Apart from the absence in most myxopapillary ependymomas, neither staining pattern was related to tumor grade or localization. Dot-like EMA immunoreactivity was less frequently observed in glioblastomas [32/54 (59%), P<0.05 vs ependymomas], fibrillary astrocytomas [10/43 (23%), P<0.001 vs ependymomas] and oligodendrogliomas [2/21 (10%), P<0.001 vs ependymomas], whereas ring-like EMA staining was absent. Sensitivity and specificity of punctate EMA staining for the diagnosis of ependymoma as compared to other glial tumors were determined: A finding of 5 EMA dots/high-power field was associated with a sensitivity of 72% and a specificity of 81%. The presence of ring-like EMA positive structures was less sensitive (32%), but highly specific (100%). To conclude, distinct punctate and ring-like EMA staining might serve as sensitive and specific markers of ependymal differentiation in glial tumors and, thus, may aid the diagnosis of ependymoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12898159     DOI: 10.1007/s00401-003-0752-8

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  10 in total

1.  Immunohistochemical study of CD99 and EMA expression in ependymomas.

Authors:  Soheir Mahfouz; Ahmad Abdel Aziz; Samia M Gabal; Samar el-Sheikh
Journal:  Medscape J Med       Date:  2008-02-19

Review 2.  EANO guidelines for the diagnosis and treatment of ependymal tumors.

Authors:  Roberta Rudà; Guido Reifenberger; Didier Frappaz; Stefan M Pfister; Anne Laprie; Thomas Santarius; Patrick Roth; Joerg Christian Tonn; Riccardo Soffietti; Michael Weller; Elizabeth Cohen-Jonathan Moyal
Journal:  Neuro Oncol       Date:  2018-03-27       Impact factor: 12.300

3.  NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma.

Authors:  Maria-Magdalena Georgescu; Paul Yell; Bret C Mobley; Ping Shang; Theodora Georgescu; Shih-Hsiu J Wang; Peter Canoll; Kimmo J Hatanpaa; Charles L White; Jack M Raisanen
Journal:  Acta Neuropathol Commun       Date:  2015-03-08       Impact factor: 7.801

Review 4.  Central Neurocytoma: A Review of Clinical Management and Histopathologic Features.

Authors:  Seung J Lee; Timothy T Bui; Cheng Hao Jacky Chen; Carlito Lagman; Lawrance K Chung; Sabrin Sidhu; David J Seo; William H Yong; Todd L Siegal; Minsu Kim; Isaac Yang
Journal:  Brain Tumor Res Treat       Date:  2016-10-31

5.  Immunohistochemical features of giant cell ependymoma of the filum terminale with unusual clinical and radiological presentation.

Authors:  Fernando Candanedo-Gonzalez; Cindy Sharon Ortiz-Arce; Samuel Rosales-Perez; Ana Lilia Remirez-Castellanos; Candelaria Cordova-Uscanga; Armando Gamboa-Dominguez
Journal:  Diagn Pathol       Date:  2017-01-14       Impact factor: 2.644

6.  YAP1/TAZ drives ependymoma-like tumour formation in mice.

Authors:  Noreen Eder; Federico Roncaroli; Marie-Charlotte Domart; Stuart Horswell; Felipe Andreiuolo; Helen R Flynn; Andre T Lopes; Suzanne Claxton; John-Paul Kilday; Lucy Collinson; Jun-Hao Mao; Torsten Pietsch; Barry Thompson; Ambrosius P Snijders; Sila K Ultanir
Journal:  Nat Commun       Date:  2020-05-13       Impact factor: 14.919

7.  Intracytoplasmic dot-like inclusions as cytopathologically useful findings of ependymoma: Case report of adolescent supratentorial anaplastic ependymoma with clear cell morphology.

Authors:  Taku Homma; Reina Mizuno; Yu Miyama; Tomonari Suzuki; Eita Uchida; Jun-Ichi Adachi; Masanori Yasuda
Journal:  Clin Case Rep       Date:  2020-11-16

8.  Cytokeratin positivity in myxopapillary ependymoma--a potential diagnostic pitfall.

Authors:  Sundus A Hussein; Monalisa Sur
Journal:  Diagn Pathol       Date:  2008-10-19       Impact factor: 2.644

9.  Trisomy 19 ependymoma, a newly recognized genetico-histological association, including clear cell ependymoma.

Authors:  Emmanuel Rousseau; Thomas Palm; Francesco Scaravilli; Marie-Magdeleine Ruchoux; Dominique Figarella-Branger; Isabelle Salmon; David Ellison; Catherine Lacroix; Françoise Chapon; Jacqueline Mikol; Miikka Vikkula; Catherine Godfraind
Journal:  Mol Cancer       Date:  2007-07-12       Impact factor: 27.401

10.  Supratentorial intraventricular rosette-forming glioneuronal tumors - Case report and review of treatment paradigms.

Authors:  Anil K Mahavadi; Caroline Temmins; Mahesh R Patel; Harminder Singh
Journal:  Surg Neurol Int       Date:  2020-06-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.